A. Bak

S. Frokjaer, B. Larsen, M. Fich, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Prodrugs of peptides obtained by derivatization of the C-terminal peptide bond in order to effect protection against degradation by carboxypeptidases

S. Frokjaer, B. Larsen, A. Bak, 1996 .

Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines.

T. Bush, Grace Chung, R. Radinsky, 2015, Journal of Medicinal Chemistry.

Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer

James J. Cunningham, A. Bak, L. Crocker, 2014, The AAPS Journal.

Physicochemical Properties of Pharmaceutical Co-Crystals: A Case Study of Ten AMG 517 Co-Crystals

A. Bak, Annette Bak, Mary K. Stanton, 2008 .

Solubility and Dissolution Considerations for Amorphous Solid Dispersions

A. Bak, A. Templeton, Allen C. Templeton, 2015 .

Two Novel Pharmaceutical Cocrystals of a Development Compound – Screening, Scale-up, and Characterization

A. Bak, R. Ball, N. Canfield, 2012 .

Local delivery of macromolecules to treat diseases associated with the colon

David J Brayden, M. Ashford, A. Bak, 2018, Advanced drug delivery reviews.

The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics.

Sekhar Surapaneni, Sesha Neervannan, R. Syed, 2008, Journal of pharmaceutical sciences.

Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans

Mark J. Rose, Andrej A. Romanovsky, A. A. Romanovsky, 2008, PAIN.

Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.

Kathy Lyons, Ping Chen, Dennis Feng, 2014, Journal of medicinal chemistry.

Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.

T. Bush, Marc Payton, Grace Chung, 2010, Cancer research.

Recent advances in polymeric materials for the delivery of RNA therapeutics

Venkata R. Krishnamurthy, John T. Wilson, David Ulkoski, 2019, Expert opinion on drug delivery.

Therapeutics , Targets , and Chemical Biology Preclinical Evaluation of AMG 900 , a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines

T. Bush, Marc Payton, Grace Chung, 2010 .

A Novel Method for Preparing Stabilized Amorphous Solid Dispersion Drug Formulations Using Acoustic Fusion.

Linan Liu, Keun-joong Lee, G. Salituro, 2020, International journal of pharmaceutics.

A new and improved method for the preparation of drug nanosuspension formulations using acoustic mixing technology.

David J. Lamberto, Linan Liu, E. Kwong, 2014, International journal of pharmaceutics.

Drug Substance and Former Structure Property Relationships in 15 Diverse Pharmaceutical Co-Crystals

A. Bak, Annette Bak, Mary K. Stanton, 2009 .

Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase.

Xin Huang, Christopher Mohr, Paul Hughes, 2009, Bioorganic & medicinal chemistry letters.

Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations.

A. Bak, S. Bhardwaj, Maya P. Lipert, 2017, Journal of pharmaceutical sciences.

Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade

J. Treanor, L. Arik, C. Henley, 2007, Journal of Pharmacology and Experimental Therapeutics.

The enzymatic degradation and transport of leucine-enkephalin and 4-imidazolidinone enkephalin prodrugs at the blood-brain barrier

L. Lund, L. Christrup, L. Hovgaard, 1998 .

Peptide Developability at the Discovery-to-Development Interface—Current State and Future Opportunities

A. Bak, W. Dai, 2015, AAPS Journal.

Acyloxyalkoxy-Based Cyclic Prodrugs of Opioid Peptides: Evaluation of the Chemical and Enzymatic Stability as Well as Their Transport Properties Across Caco-2 Cell Monolayers

R. Borchardt, A. Bak, T. Siahaan, 2004, Pharmaceutical Research.

Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate.

John J. Cummings, Scott E. Fauty, A. Bak, 2014, Journal of pharmaceutical sciences.

Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using an (acyloxy)alkoxy linker.

R. Borchardt, A. Bak, T. Siahaan, 1999, The journal of peptide research : official journal of the American Peptide Society.